A systematic review of 123 studies investigated the safety of intravenous thrombolytics during pregnancy. The analysis included 216 patients (median age 31 years) who received thrombolytics, of whom 85 had ischemic stroke. Of the 32 reported fetal deaths, thrombolytic treatment was considered a likely contributing factor in six cases, including three in patients with ischemic stroke.

Compared with published rates in the general pregnant population, the risks of miscarriage and stillbirth were 12.4% and 5.9% higher, respectively. However, the proportion of pregnant patients experiencing symptomatic intracerebral hemorrhage was similar to that reported in young, nonpregnant patients receiving thrombolytics. These findings suggest that thrombolytics may have contributed to a small proportion of fetal deaths during pregnancy, with higher rates of miscarriage and stillbirth observed in the…